Benefits from practices of pharmaceutical care in hypertension and type 2 diabetes to be conducted in health units

Abstract

Patients with chronic diseases, especially hypertension and diabetes, need  constant monitoring by health professionals, since the lack of control of both, blood glucose and blood pressure, are the precursors of fatal attacks on the kidney functions, cardiovascular problems on top of generating costs to the Public Health System. The main goal of the work is to seek evidence to corroborate the benefits of Pharmaceutical Care to patients with chronic non-communicable diseases, in particular, hypertension and diabetes. The research is a narrative review based on articles available in the scientific databases Web of Science, SciELO, Virtual Health Library, USP Bibliographic Database (DEDALUS) and PubMed-NCBI, as well as, on epidemiological data found in DATASUS as well as on Brazilian and international guidelines associated with hypertension and diabetes. The inclusion criteria established was to consider complete articles addressing the main goal of the research, from 2000 up to 2016, written in Portuguese, English or Spanish, presenting conclusive results. The exclusion criteria were satisfied by publications that did not meet the inclusion criteria. It was observed that the practice of pharmaceutical care had an impact on the adherence rate to treatment in hypertensive and/or diabetic patients, providing clinical improvement and increasing the quality of life, also generating socioeconomic benefits. It is important to emphasize that Pharmaceutical Care is not offered in isolation from other health services, but in collaboration with patients as well as with the multidisciplinary health team; by having each professional acting in their field of expertise benefits both, i.e., the patient and the public health system.